{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:13:16Z","timestamp":1780668796587,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11606-025-10025-7","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:21:59Z","timestamp":1768400519000},"page":"2256-2267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Enduring Impact of Ghostwriting on the Treatment of Alcohol Withdrawal"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8082-2068","authenticated-orcid":false,"given":"Steven J.","family":"Weintraub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"10025_CR1","doi-asserted-by":"publisher","unstructured":"Piker P, Cohn JV. The comprehensive management of delirium tremens, including treatment utilized in 300 consecutive cases. JAMA. 1937;108(5):345-9. https:\/\/doi.org\/10.1001\/jama.1937.02780050001001","DOI":"10.1001\/jama.1937.02780050001001"},{"key":"10025_CR2","doi-asserted-by":"publisher","unstructured":"Rosenbaum M. The cerebrospinal fluid in delirium tremens. JAMA. 1941;116(22):2487\u20138. https:\/\/doi.org\/10.1001\/jama.1941.02820220029007","DOI":"10.1001\/jama.1941.02820220029007"},{"key":"10025_CR3","doi-asserted-by":"publisher","unstructured":"Robinson GW. The treatment of delirium tremens with insulin in sub-shock doses. Am J Psychiatry. 1940;97(1):136-51. https:\/\/doi.org\/10.1176\/ajp.97.1.136","DOI":"10.1176\/ajp.97.1.136"},{"key":"10025_CR4","unstructured":"Associated Press. Delirium tremens yields to insulin. New York Times. November 16, 1938. Available at: https:\/\/www.nytimes.com\/1938\/11\/16\/archives\/delirium-tremens-yields-to-insulin-successful-use-in-small-doses-in.html. Accessed 3 Sept 2025."},{"key":"10025_CR5","unstructured":"Bell RG. The treatment of alcohol withdrawal symptoms. Can Med Assoc J. 1951;64(6):510-3."},{"key":"10025_CR6","doi-asserted-by":"publisher","unstructured":"Thomas DW, Freedman DX. Treatment of the alcohol withdrawal syndrome: comparison of promazine and paraldehyde. JAMA. 1964;188(3):316-8. https:\/\/doi.org\/10.1001\/jama.1964.03060290120044","DOI":"10.1001\/jama.1964.03060290120044"},{"key":"10025_CR7","doi-asserted-by":"publisher","unstructured":"Sereny G, Kalant H. Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol-withdrawal syndrome. BMJ. 1965;1(5427):92-7. https:\/\/doi.org\/10.1136\/bmj.1.5427.92","DOI":"10.1136\/bmj.1.5427.92"},{"key":"10025_CR8","doi-asserted-by":"crossref","unstructured":"Golbert TM, Sanz CJ, Rose HD, Leitschuh TH. Comparative evaluation of treatments of alcohol withdrawal syndromes. JAMA. 1967;201(2):99-102.","DOI":"10.1001\/jama.1967.03130020045009"},{"key":"10025_CR9","doi-asserted-by":"publisher","unstructured":"Kaim SC, Klett CJ, Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry. 1969;125(12):1640-6. https:\/\/doi.org\/10.1176\/ajp.125.12.1640","DOI":"10.1176\/ajp.125.12.1640"},{"key":"10025_CR10","unstructured":"Sellers EM. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Alcohol Health Res World. 1995;19(1):34-5."},{"key":"10025_CR11","doi-asserted-by":"publisher","unstructured":"Thompson WL, Johnson AD, Maddrey WL. Diazepam and paraldehyde for treatment of severe delirium tremens: a controlled trial. Ann Intern Med. 1975;82(2):175-80. https:\/\/doi.org\/10.7326\/0003-4819-82-2-175","DOI":"10.7326\/0003-4819-82-2-175"},{"key":"10025_CR12","doi-asserted-by":"publisher","unstructured":"Weintraub SJ. Diazepam in the treatment of moderate to severe alcohol withdrawal. CNS Drugs. 2017;31(2):87-95. https:\/\/doi.org\/10.1007\/s40263-016-0403-y","DOI":"10.1007\/s40263-016-0403-y"},{"key":"10025_CR13","doi-asserted-by":"publisher","unstructured":"Thompson WL. Management of alcohol withdrawal syndromes. Arch Intern Med. 1978;138(2):278-83. https:\/\/doi.org\/10.1001\/archinte.1978.03630260068019","DOI":"10.1001\/archinte.1978.03630260068019"},{"key":"10025_CR14","doi-asserted-by":"publisher","unstructured":"Ronan MV, Gordon KS, Skanderson M, et al. Contemporary management and outcomes of veterans hospitalized with alcohol withdrawal: a multicenter retrospective cohort study. J Addict Med. 2024;18(4):389-96. https:\/\/doi.org\/10.1097\/ADM.0000000000001297","DOI":"10.1097\/ADM.0000000000001297"},{"key":"10025_CR15","doi-asserted-by":"publisher","unstructured":"American Society of Addiction Medicine. The ASAM clinical practice guideline on alcohol withdrawal management. J Addict Med. 2020;14(Suppl 1):1-72. https:\/\/doi.org\/10.1097\/ADM.0000000000000668","DOI":"10.1097\/ADM.0000000000000668"},{"key":"10025_CR16","doi-asserted-by":"publisher","unstructured":"Greenblatt DJ, Shader RI, MacLeod SM, Sellers EM. Clinical pharmacokinetics of chlordiazepoxide. Clin Pharmacokinet. 1978;3(5):381-94. https:\/\/doi.org\/10.2165\/00003088-197803050-00004","DOI":"10.2165\/00003088-197803050-00004"},{"key":"10025_CR17","unstructured":"Hein\u00e4l\u00e4 P, Piepponen T, Heikkinen H. Diazepam loading in alcohol withdrawal: clinical pharmacokinetics. Int J Clin Pharmacol Ther Toxicol. 1990;28(5):211-7."},{"key":"10025_CR18","doi-asserted-by":"publisher","unstructured":"Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010;(3):CD005063. https:\/\/doi.org\/10.1002\/14651858.CD005063.pub3","DOI":"10.1002\/14651858.CD005063.pub3"},{"key":"10025_CR19","doi-asserted-by":"publisher","unstructured":"Anton RF, Kranzler HR, McEvoy JP, Moak DH, Bianca R. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Psychopharmacology. 1997;131(2):123-9. https:\/\/doi.org\/10.1007\/s002130050274","DOI":"10.1007\/s002130050274"},{"key":"10025_CR20","doi-asserted-by":"publisher","unstructured":"Day E, Patel J, Georgiou G. Evaluation of a symptom-triggered front-loading detoxification technique for alcohol dependence: a pilot study. Psychiatr Bull. 2004;28(11):407-10. https:\/\/doi.org\/10.1192\/pb.28.11.407","DOI":"10.1192\/pb.28.11.407"},{"key":"10025_CR21","doi-asserted-by":"publisher","unstructured":"Kumar CN, Andrade C, Murthy P. A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. J Stud Alcohol Drugs. 2009;70(3):467-74. https:\/\/doi.org\/10.15288\/jsad.2009.70.467","DOI":"10.15288\/jsad.2009.70.467"},{"key":"10025_CR22","unstructured":"Miller WC, McCurdy L. A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome. Clin Ther. 1984;6(3):364-71."},{"key":"10025_CR23","doi-asserted-by":"crossref","unstructured":"Ritson B, Chick J. Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery. Drug Alcohol Depend. 1986;18(4):329-34.","DOI":"10.1016\/0376-8716(86)90095-5"},{"key":"10025_CR24","unstructured":"Solomon J, Rouck LA, Koepke HH. Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome. Clin Ther. 1983;6(1):52-8."},{"key":"10025_CR25","doi-asserted-by":"publisher","unstructured":"Wilson A, Vulcano BA. Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome. Alcohol Clin Exp Res. 1985;9(1):23-7. https:\/\/doi.org\/10.1111\/j.1530-0277.1985.tb05043.x","DOI":"10.1111\/j.1530-0277.1985.tb05043.x"},{"key":"10025_CR26","doi-asserted-by":"publisher","unstructured":"Brickel KH, Hodge EK, Zavgorodnyaya D, Schroeder JM, Brown LH, Daley MJ. A comparison of injectable diazepam and lorazepam in the goal-directed management of severe alcohol withdrawal. Ann Pharmacother. 2024 May;58(5):453-460. https:\/\/doi.org\/10.1177\/10600280231194790","DOI":"10.1177\/10600280231194790"},{"key":"10025_CR27","doi-asserted-by":"publisher","unstructured":"Levine AR, Thanikonda V, Mueller J, Naut ER. Front-loaded diazepam versus lorazepam for treatment of alcohol withdrawal agitated delirium. Am J Emerg Med. 2021;44:415-8. https:\/\/doi.org\/10.1016\/j.ajem.2020.04.095","DOI":"10.1016\/j.ajem.2020.04.095"},{"key":"10025_CR28","doi-asserted-by":"publisher","unstructured":"March KL, Twilla JD, Reaves AB, et al. Lorazepam versus chlordiazepoxide for the treatment of alcohol withdrawal syndrome and prevention of delirium tremens in general medicine ward patients. Alcohol. 2019;81:56-60. https:\/\/doi.org\/10.1016\/j.alcohol.2019.05.008","DOI":"10.1016\/j.alcohol.2019.05.008"},{"key":"10025_CR29","doi-asserted-by":"publisher","unstructured":"Rajmohan V, Sushil K, Mohandas E. A double-blind randomised comparison of chlordiazepoxide and lorazepam in alcohol withdrawal. Asian J Psychiatry. 2013;6(5):401-3. https:\/\/doi.org\/10.1016\/j.ajp.2013.05.003","DOI":"10.1016\/j.ajp.2013.05.003"},{"key":"10025_CR30","doi-asserted-by":"publisher","unstructured":"Sand T, Br\u00e5then G, Michler R, Brodtkorb E, Helde G, Bovim G. Clinical utility of EEG in alcohol-related seizures. Acta Neurol Scand. 2002;105(1):18-24. https:\/\/doi.org\/10.1034\/j.1600-0404.2002.00058.x","DOI":"10.1034\/j.1600-0404.2002.00058.x"},{"key":"10025_CR31","doi-asserted-by":"crossref","unstructured":"Rajmohan V. An open label comparison of chlordiazepoxide and lorazepam in alcohol withdrawal. J Evol Med Dent Sci. 2013;2(25):4609-13.","DOI":"10.14260\/jemds\/886"},{"key":"10025_CR32","doi-asserted-by":"publisher","unstructured":"Hill A, Williams D. Hazards associated with the use of benzodiazepines in alcohol detoxification. J Subst Abuse Treat. 1993;10(5):449-51. https:\/\/doi.org\/10.1016\/0740-5472(93)90005-M","DOI":"10.1016\/0740-5472(93)90005-M"},{"key":"10025_CR33","doi-asserted-by":"crossref","unstructured":"Mayo-Smith MF, Bernard D. Late-onset seizures in alcohol withdrawal. Alcohol Clin Exp Res. 1995;19(3):656-9.","DOI":"10.1111\/j.1530-0277.1995.tb01563.x"},{"key":"10025_CR34","unstructured":"Hoffman RS, Weinhouse GL. Management of moderate and severe alcohol withdrawal syndromes. In: Post TW, ed. UpToDate. Waltham, MA: Wolters Kluwer."},{"key":"10025_CR35","doi-asserted-by":"publisher","unstructured":"Duby JJ, Berry AJ, Ghayyem P, Wilson MD, Cocanour CS. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management. J Trauma Acute Care Surg. 2014;77(6):938-43. https:\/\/doi.org\/10.1097\/TA.0000000000000352","DOI":"10.1097\/TA.0000000000000352"},{"key":"10025_CR36","doi-asserted-by":"publisher","unstructured":"Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007;35(3):724-30. https:\/\/doi.org\/10.1097\/01.CCM.0000256841.28351.80","DOI":"10.1097\/01.CCM.0000256841.28351.80"},{"key":"10025_CR37","doi-asserted-by":"publisher","unstructured":"Korkmaz \u015eA, Aldemir E, \u00d6yek\u00e7in DG. Successful treatment of severe alcohol withdrawal delirium with very high-dose diazepam (260\u2013480 mg) administration. Curr Med Res Opin. 2024;40(3):517-21. https:\/\/doi.org\/10.1080\/03007995.2024.2313687","DOI":"10.1080\/03007995.2024.2313687"},{"key":"10025_CR38","doi-asserted-by":"publisher","unstructured":"Klein SS, Fine JS, Smith SW. Response to: \u201cEliminating the benzos: A benzodiazepinesparing approach to preventing and treating alcohol withdrawal syndrome\u201d. J Trauma Acute Care Surg. 2024;96(5):e42-3. https:\/\/doi.org\/10.1097\/TA.0000000000004264","DOI":"10.1097\/TA.0000000000004264"},{"key":"10025_CR39","doi-asserted-by":"publisher","unstructured":"Strayer RJ, Friedman BW, Haroz R, et al. Emergency department management of patients with alcohol intoxication, alcohol withdrawal, and alcohol use disorder: a white paper prepared for the American Academy of Emergency Medicine. J Emerg Med. 2023;64(4):517-40. https:\/\/doi.org\/10.1016\/j.jemermed.2023.01.010","DOI":"10.1016\/j.jemermed.2023.01.010"},{"key":"10025_CR40","doi-asserted-by":"publisher","unstructured":"Weintraub SJ. Should chlordiazepoxide and diazepam be avoided when treating alcohol withdrawal syndrome in patients with hepatic insufficiency? Clin Toxicol. 2025;63(5):303-9. https:\/\/doi.org\/10.1080\/15563650.2025.2493216","DOI":"10.1080\/15563650.2025.2493216"},{"key":"10025_CR41","doi-asserted-by":"publisher","unstructured":"Gottlieb M, Chien N, Moyer E, Bernard K, Peksa GD. Alcohol withdrawal syndrome presentations to emergency departments in the United States from 2015 to 2023. Acad Emerg Med. 2025;32(7):785-791. https:\/\/doi.org\/10.1111\/acem.15093","DOI":"10.1111\/acem.15093"},{"key":"10025_CR42","doi-asserted-by":"publisher","unstructured":"Erfle BA, Steel TL, Law AC, et al. Pharmacological interventions for alcohol withdrawal syndrome among hospitalized adults: a multicenter cohort study. J Gen Intern Med. Published online 2025. https:\/\/doi.org\/10.1007\/s11606-025-09817-8","DOI":"10.1007\/s11606-025-09817-8"},{"key":"10025_CR43","doi-asserted-by":"publisher","unstructured":"Steel TL, Malte CA, Bradley KA, Hawkins EJ. Benzodiazepine treatment and hospital course of medical inpatients with alcohol withdrawal syndrome in the Veterans Health Administration. Mayo Clin Proc Innov Qual Outcomes. 2022;6(2):126-36. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.11.010","DOI":"10.1016\/j.mayocpiqo.2021.11.010"},{"key":"10025_CR44","doi-asserted-by":"publisher","unstructured":"Esteves AM, Buchfellner MC, Holmes BM, Berndsen JA, Roginski MA. Impact of a divided phenobarbital load and taper compared with lorazepam symptom-triggered therapy in hospitalized patients. Ann Pharmacother. 2024;58(9):896-905. https:\/\/doi.org\/10.1177\/10600280231222294","DOI":"10.1177\/10600280231222294"},{"key":"10025_CR45","doi-asserted-by":"publisher","unstructured":"Hawa F, Gilbert L, Gilbert B, et al. Phenobarbital versus lorazepam for management of alcohol withdrawal syndrome: a retrospective cohort study. Cureus. 2021;13(2):e13282. https:\/\/doi.org\/10.7759\/cureus.13282","DOI":"10.7759\/cureus.13282"},{"key":"10025_CR46","doi-asserted-by":"publisher","unstructured":"Nguyen TA, Lam SW. Phenobarbital and symptom-triggered lorazepam versus lorazepam alone for severe alcohol withdrawal in the intensive care unit. Alcohol. 2020;82:23-7. https:\/\/doi.org\/10.1016\/j.alcohol.2019.07.004","DOI":"10.1016\/j.alcohol.2019.07.004"},{"key":"10025_CR47","doi-asserted-by":"publisher","unstructured":"Ibarra F. Single dose phenobarbital in addition to symptom-triggered lorazepam in alcohol withdrawal. Am J Emerg Med. 2020;38(2):178-81. https:\/\/doi.org\/10.1016\/j.ajem.2019.01.053","DOI":"10.1016\/j.ajem.2019.01.053"},{"key":"10025_CR48","doi-asserted-by":"publisher","unstructured":"Morrison M, Udeh E, Burak M. Retrospective analysis of a gabapentin high dose taper compared to lorazepam in acute inpatient alcohol withdrawal. Am J Drug Alcohol Abuse. 2019;45(4):385-91. https:\/\/doi.org\/10.1080\/00952990.2019.1602136","DOI":"10.1080\/00952990.2019.1602136"},{"key":"10025_CR49","doi-asserted-by":"publisher","unstructured":"Mueller SW, Preslaski CR, Kiser TH, et al. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med. 2014;42(5):1131-9. https:\/\/doi.org\/10.1097\/CCM.0000000000000141","DOI":"10.1097\/CCM.0000000000000141"},{"key":"10025_CR50","doi-asserted-by":"publisher","unstructured":"Hendey GW, Dery RA, Barnes RL, Snowden B, Mentler P. A prospective, randomized trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. Am J Emerg Med. 2011;29(4):382-5. https:\/\/doi.org\/10.1016\/j.ajem.2009.10.010","DOI":"10.1016\/j.ajem.2009.10.010"},{"key":"10025_CR51","doi-asserted-by":"publisher","unstructured":"Sellers EM, Kalant H. Alcohol intoxication and withdrawal. N Engl J Med. 1976;294(14):757-62. https:\/\/doi.org\/10.1056\/NEJM197604012941405","DOI":"10.1056\/NEJM197604012941405"},{"key":"10025_CR52","unstructured":"O\u2019Brien JE, Meyer RE, Thoms DC. Double-blind comparison of lorazepam and diazepam in the treatment of the acute alcohol abstinence syndrome. Curr Ther Res Clin Exp. 1983;34(5):825-31."},{"key":"10025_CR53","doi-asserted-by":"publisher","unstructured":"Goldzieher JW, Chenault CB, Woutersz TB, Schneider BE, Hansen PR. Clinical effects of ethynyl estrogens, used with and without progestational agents, on bleeding patterns, weight, and blood pressure. Contraception. 1980;22:369-81. https:\/\/doi.org\/10.1016\/0010-7824(80)90022-0","DOI":"10.1016\/0010-7824(80)90022-0"},{"key":"10025_CR54","doi-asserted-by":"publisher","unstructured":"Deitch MW, Littman GS, Pascucci VL. Antihypertensive therapy with guanabenz in patients with chronic obstructive pulmonary diseases. J Cardiovasc Pharmacol. 1984;6(Suppl 5):S818-22. https:\/\/doi.org\/10.1097\/00005344-198400065-00018","DOI":"10.1097\/00005344-198400065-00018"},{"key":"10025_CR55","doi-asserted-by":"publisher","unstructured":"Fugh-Berman AJ. The haunting of medical journals: how ghostwriting sold \u201cHRT\u201d. PLoS Med. 2010;7(9):e1000335. https:\/\/doi.org\/10.1371\/journal.pmed.1000335","DOI":"10.1371\/journal.pmed.1000335"},{"key":"10025_CR56","doi-asserted-by":"publisher","unstructured":"G\u00f8tzsche PC, Hr\u00f3bjartsson A, Johansen HK, Haahr MT, Altman DG, Chan AW. Ghost authorship in industry-initiated randomised trials. PLoS Med. 2007;4(1):e19. https:\/\/doi.org\/10.1371\/journal.pmed.0040019","DOI":"10.1371\/journal.pmed.0040019"},{"key":"10025_CR57","doi-asserted-by":"publisher","unstructured":"Elliott C. Pharma goes to the laundry: public relations and the business of medical education. Hastings Cent Rep. 2004;34(5):18-23. https:\/\/doi.org\/10.2307\/3527586","DOI":"10.2307\/3527586"},{"key":"10025_CR58","unstructured":"House of Commons. The influence of the pharmaceutical industry. Volume II. London: The Stationery Office; 2005. https:\/\/publications.parliament.uk\/pa\/cm200405\/cmselect\/cmhealth\/42\/42ii.pdf. Accessed September 3, 2025."},{"key":"10025_CR59","doi-asserted-by":"publisher","unstructured":"Angell M. Is academic medicine for sale? N Engl J Med. 2000;342(20):1516-8. https:\/\/doi.org\/10.1056\/NEJM200005183422009","DOI":"10.1056\/NEJM200005183422009"},{"key":"10025_CR60","doi-asserted-by":"publisher","unstructured":"Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-80. https:\/\/doi.org\/10.1001\/jama.283.3.373","DOI":"10.1001\/jama.283.3.373"},{"key":"10025_CR61","doi-asserted-by":"publisher","unstructured":"Lichstein PR, Turner RC, O\u2019Brien K. Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med. 1992;152(5):1009-13. https:\/\/doi.org\/10.1001\/archinte.1992.00400170093018","DOI":"10.1001\/archinte.1992.00400170093018"},{"key":"10025_CR62","doi-asserted-by":"publisher","unstructured":"Stryer D, Bero LA. Characteristics of materials distributed by drug companies. J Gen Intern Med. 1996;11(10):575-83. https:\/\/doi.org\/10.1007\/BF02599024","DOI":"10.1007\/BF02599024"},{"key":"10025_CR63","doi-asserted-by":"publisher","unstructured":"Stafford RS. Regulating off-label drug use\u2014rethinking the role of the FDA. N Engl J Med. 2008;358(14):1427-9. https:\/\/doi.org\/10.1056\/NEJMp0802107","DOI":"10.1056\/NEJMp0802107"},{"key":"10025_CR64","unstructured":"Mundy A. Dispensing with the truth: the victims, the drug companies, and the dramatic story behind the battle over Fen-Phen. New York: St. Martin\u2019s Press; 2001."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-10025-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:33:47Z","timestamp":1780666427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-10025-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10025"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-10025-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The author declares that he does not have a conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}